세계의 AI 기반 자폐 스펙트럼 스크리닝 툴 시장 예측(-2032년) : 스크리닝 유형, 컴포넌트, 연령대, 전개 모드, 최종 사용자, 지역별 분석

According to Stratistics MRC, the Global AI-Based Autism Spectrum Screening Tools Market is accounted for $2.1 billion in 2025 and is expected to reach $6.8 billion by 2032 growing at a CAGR of 18.6% during the forecast period. AI-Based Autism Spectrum Screening Tools are advanced digital systems that leverage artificial intelligence, machine learning, and data analytics to detect early signs of autism spectrum disorder (ASD) in children and adults. These tools analyze complex behavioral patterns, speech, facial expressions, eye-tracking data, and other developmental indicators to provide accurate, objective, and timely assessments. Unlike traditional screening methods that rely heavily on clinician observation and subjective reporting, AI-driven tools enhance precision, reduce diagnostic delays, and enable remote or telehealth-based evaluations. By combining vast datasets with intelligent algorithms, they support early intervention, personalized care plans, and improved long-term outcomes for individuals with ASD.

Market Dynamics:

Driver:

Rising Prevalence and Awareness

The rising prevalence of autism spectrum disorder (ASD) and growing public awareness are fueling demand for early, accurate diagnosis, driving the adoption of AI-based screening tools. As more families and healthcare providers recognize the importance of timely intervention, AI-powered solutions offer scalable, objective assessments that overcome limitations of traditional methods. This heightened awareness encourages investment, innovation, and integration of intelligent technologies into clinical workflows, accelerating market growth and improving access to personalized care for individuals with ASD.

Restraint:

Data Privacy and Ethical Concerns

Data privacy and ethical concerns pose significant barriers to the growth of AI-based autism spectrum screening tools. These systems rely on sensitive personal data, including biometric and behavioral information, raising issues around consent, data protection, and algorithmic transparency. Fear of misuse or breaches can deter adoption among users and healthcare providers. Without robust safeguards and clear ethical frameworks, trust in these technologies may erode, slowing market expansion and limiting their clinical integration.

Opportunity:

Advancements in AI and Machine Learning

Advancements in AI and machine learning are revolutionizing autism spectrum screening by enabling faster, more accurate and scalable assessments. These technologies analyze complex behavioral data-such as speech, facial expressions, and eye movement-with unprecedented precision, reducing diagnostic delays and human bias. Continuous algorithm improvements support adaptive learning and personalized care plans, while integration with mobile platforms expands access to remote evaluations. This innovation surge is propelling market growth, making AI-based tools indispensable in modern autism diagnostics.

Threat:

Environmental and climate challenges

Environmental and climate challenges can hinder the growth of AI-based autism spectrum screening tools by disrupting healthcare infrastructure and digital connectivity, especially in vulnerable regions. Extreme weather events, power outages, and resource scarcity may limit access to telehealth platforms and wearable technologies essential for remote diagnostics. These disruptions can delay assessments, reduce data reliability, and strain healthcare systems, ultimately slowing the adoption and scalability of AI-driven autism screening solutions.

Covid-19 Impact:

The COVID-19 pandemic accelerated the adoption of AI-based autism screening tools by highlighting the need for remote and contactless diagnostic solutions. Lockdowns and social distancing measures disrupted traditional in-person assessments, prompting a shift toward telehealth platforms. AI tools enabled continued screening and monitoring of ASD symptoms, especially in children missing regular clinical visits. The pandemic underscored the value of scalable, data-driven technologies in maintaining continuity of care and supporting early intervention during public health crises.

The wearable sensor-based tools segment is expected to be the largest during the forecast period

The wearable sensor-based tools segment is expected to account for the largest market share during the forecast period due to their ability to continuously monitor physiological and behavioral indicators in real-time. These devices capture subtle cues such as movement patterns, heart rate variability, and eye-tracking data, offering objective insights into ASD symptoms. Their non-invasive nature and compatibility with mobile platforms make them ideal for home-based assessments. As sensor technology becomes more sophisticated, wearable tools will play a pivotal role in early autism detection and personalized care.

The diagnostic centers segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the diagnostic centers segment is predicted to witness the highest growth rate owing to increasing demand for specialized autism screening services. These centers offer structured environments, access to trained professionals, and integration of advanced AI tools for comprehensive assessments. As awareness grows and healthcare infrastructure improves, more families are turning to diagnostic centers for accurate and timely evaluations. Their role in validating AI-based tools and facilitating early intervention contributes to their rapid market expansion.

Region with largest share:

During the forecast period, the Asia Pacific region is expected to hold the largest market share because of its vast population base, rising awareness of developmental disorders, and expanding healthcare infrastructure. Countries like China, India, and Japan are investing in digital health technologies, including AI-driven screening tools, to address growing ASD prevalence. Government initiatives, increased funding, and partnerships with tech firms are accelerating adoption. The region's focus on early childhood development and education further supports the integration of AI in autism diagnostics.

Region with highest CAGR:

Over the forecast period, the North America region is anticipated to exhibit the highest CAGR due to technological innovation, strong healthcare systems, and supportive regulatory frameworks. The U.S. and Canada lead in AI research and development, enabling rapid deployment of autism screening tools across clinical and telehealth settings. High awareness levels, insurance coverage, and collaborations between academia and industry drive growth. The region's emphasis on personalized medicine and digital transformation positions it as a key hub for AI-based autism diagnostics.

Key players in the market

Some of the key players in AI-Based Autism Spectrum Screening Tools Market include Cognoa Inc., Affectiva Inc., Brain Power LLC, Akili Interactive Labs, Autism Speaks, Microsoft Corporation, Behavior Imaging, IBM Corporation, Qr8 Health, Google LLC, Otsuka Pharmaceutical Co., Ltd., Apple Inc., F. Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc. and H. Lundbeck A/S.

Key Developments:

In February 2025, Anduril Industries and Microsoft announced an expanded partnership to advance the U.S. Army's Integrated Visual Augmentation System (IVAS). Pending Department of Defense approval, Anduril will assume oversight of production, hardware and software development, and delivery timelines, while Microsoft Azure remains the preferred cloud provider for IVAS and Anduril AI technologies

In January 2024, Microsoft and OpenAI announced an evolution of their strategic partnership, extending their collaboration through 2030. Key elements include Microsoft's exclusive rights to OpenAI's intellectual property for integration into products like Copilot, continued revenue-sharing agreements, and Azure's exclusive hosting of OpenAI's API.

Screening Types Covered:

• Behavioral Pattern Recognition Tools
• Wearable Sensor-Based Tools
• Speech & Language Analysis Tools
• Facial Recognition & Eye-Tracking Tools
• Other Screening Types

Components Covered:

• Software Platforms
• Hardware Devices
• Services

Age Groups Covered:

• Infants & Toddlers (0-3 years)
• Adolescents (13-18 years)
• Children (4-12 years)
• Adults

Deployment Modes Covered:

• Cloud-Based Solutions
• On-Premises Solutions

End Users Covered:

• Hospitals & Clinics
• Homecare & Individual Use
• Diagnostic Centers
• Research & Academic Institutions
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 End User Analysis
• 3.7 Emerging Markets
• 3.8 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global AI-Based Autism Spectrum Screening Tools Market, By Screening Type

• 5.1 Introduction
• 5.2 Behavioral Pattern Recognition Tools
• 5.3 Wearable Sensor-Based Tools
• 5.4 Speech & Language Analysis Tools
• 5.5 Facial Recognition & Eye-Tracking Tools
• 5.6 Other Screening Types

6 Global AI-Based Autism Spectrum Screening Tools Market, By Component

• 6.1 Introduction
• 6.2 Software Platforms
• 6.3 Hardware Devices
• 6.4 Services

7 Global AI-Based Autism Spectrum Screening Tools Market, By Age Group

• 7.1 Introduction
• 7.2 Infants & Toddlers (0-3 years)
• 7.3 Adolescents (13-18 years)
• 7.4 Children (4-12 years)
• 7.5 Adults

8 Global AI-Based Autism Spectrum Screening Tools Market, By Deployment Mode

• 8.1 Introduction
• 8.2 Cloud-Based Solutions
• 8.3 On-Premises Solutions

9 Global AI-Based Autism Spectrum Screening Tools Market, By End User

• 9.1 Introduction
• 9.2 Hospitals & Clinics
• 9.3 Homecare & Individual Use
• 9.4 Diagnostic Centers
• 9.5 Research & Academic Institutions
• 9.6 Other End Users

10 Global AI-Based Autism Spectrum Screening Tools Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 Cognoa Inc.
• 12.2 Affectiva In
• 12.3 Brain Power LLC
• 12.4 Akili Interactive Labs
• 12.5 Autism Speaks
• 12.6 Microsoft Corporation
• 12.7 Behavior Imaging
• 12.8 IBM Corporation
• 12.9 Qr8 Health
• 12.10 Google LLC
• 12.11 Otsuka Pharmaceutical Co., Ltd.
• 12.12 Apple Inc.
• 12.13 F. Hoffmann-La Roche Ltd
• 12.14 Thermo Fisher Scientific Inc.
• 12.15 H. Lundbeck A/S